Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Aug 25, 2011

Promega Plans 260,000-Square-Foot Facility for Molecular Bio Products

  • Promega broke ground today for a cGMP facility for FDA-regulated molecular biology products. These include components such as sample preparation systems and reagents that are part of diagnostic and medical tests sold by human diagnostic test providers.

    The 260,000 square foot facility will employ an additional 100 people in the next five years. Most of the building will be dedicated to manufacturing with both committed production lines and flexible manufacturing areas.

    Plans include a number of environmentally sensitive construction practices. Some of those practices include geothermal heating and cooling, dark sky compliant lighting, prairie restoration, bioretention ponds for storm water run-off, among other sustainable features and construction practices.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »